Trials / Conditions / ANCA Associated Systemic Vasculitis
ANCA Associated Systemic Vasculitis
5 registered clinical trials studyying ANCA Associated Systemic Vasculitis — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease NCT07507201 | The Children's Hospital of Zhejiang University School of Medicine | EARLY_Phase 1 |
| Recruiting | A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases NCT07413341 | Therorna | Phase 1 |
| Recruiting | CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116 | The Children's Hospital of Zhejiang University School of Medicine | Phase 1 |
| Enrolling By Invitation | Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases NCT05859997 | Bioray Laboratories | N/A |
| Completed | Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides NCT00430105 | Cambridge University Hospitals NHS Foundation Trust | Phase 2 / Phase 3 |